CRSP vs EIX · rev $37.3M vs P/E 7.3, rev $17.60B
Crispr Therapeutics AG (CRSP) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CRSP revenue for 2024-12-31 was $37.3M. Net income was -$366.3M. Revenue was down 89.9% from 2023-12-31 to 2024-12-31. CRSP currently screens at market cap $5.42B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CRSP currently screens at market cap $5.42B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CRSP and EIX stock pages for the full models.
Not investment advice.